Semaglutide

Price range: $26.00 through $108.00

CAS #: 910463-68-2
Molecular Formula: C₁₈₇H₂₉₁N₄₅O₅₉
Molecular Weight (M.W.): Approximately 4113.6 g/mol
Length: 31 amino-acid residues
Sequence: Modified 31-residue peptide structure
Product Type: Modified Synthetic Lipopeptide Research Material

Semaglutide is a structurally modified 31-residue peptide supplied for controlled laboratory, analytical, and scientific research.

Unlike a conventional unmodified peptide, Semaglutide contains non-standard structural features and a lipid-associated side chain. For this reason, its complete chemical identity cannot be represented accurately by a simple amino-acid sequence alone.

Its commonly referenced molecular specifications include CAS 910463-68-2, molecular formula C₁₈₇H₂₉₁N₄₅O₅₉, and molecular weight approximately 4113.6 g/mol.

Final technical documentation should be aligned with the exact product form, purity specification, counter-ion status, and lot-specific Certificate of Analysis.

Research Applications

Semaglutide may be examined in controlled non-clinical research involving:

  • Modified peptide characterization
  • Ligand-receptor interaction studies
  • Molecular signaling research
  • Structure-function analysis
  • Lipidated peptide characterization
  • Analytical comparison
  • Stability assessment
  • Non-clinical biochemical and cellular models

Any observations should remain limited to the applicable experimental system and should not be interpreted as evidence of weight-management, metabolic, therapeutic, or clinical effectiveness.

Structural Information

Semaglutide is a modified peptide containing:

  • 31 amino-acid residues
  • A non-standard amino-acid substitution
  • A chemically modified lysine residue
  • A linker-associated lipid side chain

These modifications form part of the complete molecular identity.

A simplified peptide backbone should therefore not be used as the sole structural specification for technical documentation.

Analytical Identification

Relevant analytical characterization may include:

  • Peptide identity confirmation
  • Molecular mass assessment
  • Modified-residue verification
  • Side-chain modification confirmation
  • Chromatographic purity testing
  • Mass-spectrometric analysis
  • Lot-specific quality evaluation

Specifications & Documentation

Lot-specific documentation should be reviewed for:

  • Product identity
  • CAS number
  • Molecular formula
  • Molecular weight
  • Structural modifications
  • Salt or counter-ion form
  • Purity specification
  • Analytical testing
  • Lot or batch information
  • Certificate of Analysis
  • Storage requirements

Authenticated lot-specific documentation should take precedence over generalized reference data.

Storage & Handling

Store according to the conditions specified on the product label and Certificate of Analysis. Protect the material from environmental conditions that may compromise peptide integrity.

Handling should follow established laboratory procedures appropriate for research materials.

Research Use Only

Semaglutide is supplied exclusively for laboratory research, analytical testing, and scientific reference purposes.

Disclaimer

For research use only. Not for human or veterinary use. Not intended for consumption, administration, weight-management use, metabolic use, diagnosis, treatment, mitigation, cure, or prevention of any disease. No therapeutic, metabolic, weight-related, medical, or clinical claims are made or implied. Product information is supplied solely for scientific identification, documentation, and research reference.